XML 48 R61.htm IDEA: XBRL DOCUMENT v2.4.0.8
Proforma Results Reflecting Avid Health Acquisition (Detail) (USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Business Acquisition, Pro Forma Information [Line Items]                              
Net Sales, Reported $ 822.6 $ 804.8 $ 787.6 $ 779.3 $ 809.7 [1] $ 725.2 [1] $ 696.4 [1] $ 690.6 [1] $ 731.1 $ 701.0 $ 674.9 $ 642.3 $ 3,194.3 $ 2,921.9 [1] $ 2,749.3
Net Income, Reported                         394.4 349.8 309.6
Net Income per share - Basic, Reported $ 0.66 $ 0.78 $ 0.62 $ 0.78 $ 0.58 $ 0.67 $ 0.57 $ 0.67 $ 0.45 [2] $ 0.55 [2] $ 0.58 [2] $ 0.59 [2] $ 2.85 $ 2.50 $ 2.16 [2]
Net Income per share - Diluted, Reported $ 0.65 $ 0.76 $ 0.61 $ 0.76 $ 0.57 $ 0.66 $ 0.56 $ 0.66 $ 0.44 [2] $ 0.54 [2] $ 0.57 [2] $ 0.58 [2] $ 2.79 $ 2.45 $ 2.12 [2]
Avid Health, Inc
                             
Business Acquisition, Pro Forma Information [Line Items]                              
Net Sales, Reported                           2,921.9 2,749.3
Net Income, Reported                           349.8 309.6
Net Income per share - Basic, Reported                           $ 2.50 $ 2.16
Net Income per share - Diluted, Reported                           $ 2.45 $ 2.12
Net Sales, Pro forma                           3,106.0 2,947.8
Net Income, Pro forma                           $ 374.9 $ 318.2
Net Income per share - Basic, Pro forma                           $ 2.68 $ 2.22
Net Income per share - Diluted, Pro forma                           $ 2.63 $ 2.18
[1] The fourth quarter of 2012 Net Sales includes approximately $70 associated with the acquisition of the L'IL CRITTERS and VITAFUSION gummy vitamin dietary supplement business.
[2] The fourth quarter of 2011 Net Income and Net Income per Share includes a deferred tax valuation charge of approximately $13 (or $0.09 per share) and includes an additional month's results of three foreign subsidiaries due to the change in the fiscal calendar. The change increased net sales by $14.3, but had a nominal effect on net income.